Q3FY17 results: Divis laboratories Ltd.
Bhagyashree Vivarekar / 04 Feb 2017
Divis Laboratories Ltd Ltd. reported its results for the quarter ended December 31, 2016 on Saturday. The company's standalone numbers were largely stable despite adverse observations by the US FDA observations recently.
Divis Laboratories Ltd Ltd. reported its results for the quarter ended December 31, 2016 on Saturday.
The company's standalone numbers were largely stable despite adverse observations by the US FDA observations recently.
The company's total sales for Q3FY17 were Rs 976.48 crore, which represent a 2.88 per cent sequential decline and 13.58 per cent YoY increase.
Its operating profit (EBIT) for the quarter was Rs 349.85 crore and its EBIT margin was 35.83 per cent.
The company reported PAT of Rs 268.32 crore, which represents a sequential QoQ increase of 19.87 per cent and a YoY increase of 8.74 per cent.
Divis Laboratories is Indian pharma company which provides new processes for the production of active pharma ingredients (APIs) and intermediates.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.